M. Riofrio

891 total citations
6 papers, 743 citations indexed

About

M. Riofrio is a scholar working on Cancer Research, Pharmacology and Oncology. According to data from OpenAlex, M. Riofrio has authored 6 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in M. Riofrio's work include Synthesis and Biological Activity (3 papers), Marine Sponges and Natural Products (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). M. Riofrio is often cited by papers focused on Synthesis and Biological Activity (3 papers), Marine Sponges and Natural Products (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). M. Riofrio collaborates with scholars based in France and Spain. M. Riofrio's co-authors include José Jimeno, J. L. Misset, A. Taamma, Étienne Brain, Esteban Cvitkovic, Alejandro Yovine, M. Spielmann, Laurent Zelek, Yacine Salhi and Carmen Kahatt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

M. Riofrio

6 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Riofrio France	6	448	425	218	129	105	6	743
Alejandro Yovine France	11	428 1.0×	422 1.0×	145 0.7×	118 0.9×	104 1.0×	24	732
Joan Lucca United States	12	753 1.7×	683 1.6×	62 0.3×	56 0.4×	48 0.5×	25	1.0k
Tamara Shenkier Canada	9	207 0.5×	523 1.2×	325 1.5×	51 0.4×	89 0.8×	12	816
Lambros Vamvakas Greece	17	370 0.8×	597 1.4×	164 0.8×	20 0.2×	41 0.4×	44	759
D. P. Ryan United States	13	180 0.4×	241 0.6×	83 0.4×	16 0.1×	39 0.4×	31	510
Julio Astudillo Spain	14	624 1.4×	482 1.1×	149 0.7×	18 0.1×	72 0.7×	28	1.2k
Kirsten Leu United States	10	447 1.0×	390 0.9×	54 0.2×	142 1.1×	70 0.7×	13	656
Marianna Silletta Italy	14	214 0.5×	224 0.5×	87 0.4×	30 0.2×	88 0.8×	42	613
Yousif Abubakr United States	6	498 1.1×	1.1k 2.6×	95 0.4×	12 0.1×	181 1.7×	7	1.2k
Patrizia Trenta Italy	11	229 0.5×	314 0.7×	77 0.4×	27 0.2×	52 0.5×	21	535

Countries citing papers authored by M. Riofrio

Since Specialization

Citations

This map shows the geographic impact of M. Riofrio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Riofrio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Riofrio more than expected).

Fields of papers citing papers by M. Riofrio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Riofrio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Riofrio. The network helps show where M. Riofrio may publish in the future.

Co-authorship network of co-authors of M. Riofrio

This figure shows the co-authorship network connecting the top 25 collaborators of M. Riofrio. A scholar is included among the top collaborators of M. Riofrio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Riofrio. M. Riofrio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zelek, Laurent, Alejandro Yovine, Étienne Brain, et al.. (2006). A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer. British Journal of Cancer. 94(11). 1610–1614. 77 indexed citations

2.

Yovine, Alejandro, M. Riofrio, Jean‐Yves Blay, et al.. (2004). Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients. Journal of Clinical Oncology. 22(5). 890–899. 261 indexed citations

3.

Zelek, Laurent, M. Riofrio, Karim Fizazi, et al.. (2001). Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. Cancer. 92(9). 2267–2272. 122 indexed citations

4.

Taamma, A., J. L. Misset, M. Riofrio, et al.. (2001). Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors. Journal of Clinical Oncology. 19(5). 1256–1265. 137 indexed citations

5.

Zelek, Laurent, et al.. (2001). Single-agent estramustine phosphate (EMP) is active in advanced breast cancer after failure with anthracyclines and taxanes. Annals of Oncology. 12(9). 1265–1268. 10 indexed citations

6.

Delaloge, Suzette, Alejandro Yovine, A. Taamma, et al.. (2001). Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients—Preliminary Evidence of Activity. Journal of Clinical Oncology. 19(5). 1248–1255. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact